Share:
Peer-Reviewed Publication
Clin Neuroradiol2016;26(4):423-430.December 1, 2016Clinical Trial

Between-Scanner and Between-Visit Variation in Normal White Matter Apparent Diffusion Coefficient Values in the Setting of a Multi-Center Clinical Trial.

J Huo1, J Alger2, H Kim2, M Brown2, K Okada3, W Pope2, J Goldin2
1TeraRecon Inc., 4000 E 3rd Ave., Suite 200, 94404, Foster City, CA, USA. jinghuo@gmail.com.
2Department of Radiological Science, University of California in Los Angeles, 924 Westwood Blvd, Suite 650, 90024, Los Angeles, CA, USA.
3Department of Computer Science, San Francisco State University, San Francisco, USA.

Abstract

PURPOSE: To study the between-scanner variation and the between-visit reproducibility of brain apparent diffusion coefficient (ADC) measurements in the setting of a multi-center chemotherapy clinical trial for glioblastoma multiforme. METHODS AND MATERIALS: ADC maps of 52 patients at six sites were calculated in-house from diffusion-weighted images obtained by seven individual scanner models of t…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.